Buy PhaseRx Stock | PZRX Stock Price & Latest News | Public.com
PZRX

PhaseRx

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View PhaseRx (PZRX) stock trends here

    About PZRX

    PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency; argini...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$467,6k
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.08
    1 Year Low$0.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app